🦊/Investors

Xenia Venture Capital

Venture capital

Tel Aviv · Seed–Series A · 6 people tracked

Find your way into Xenia Venture Capital

199 people in our graph share verified history with the Xenia Venture Capital team — schools, employers, funds. One of them is your warm intro.

Moran Zilbershteinunlockedknows Rotem (Yehuda) Kakon · together at Ministry of Economy and Industry, Israel (overlapped)
×10knows the team · via Bar-Ilan University
knows the team · via Ministry of Environmental Protection
Fox Verdict
Sign up to see your fit

Investment thesis

Xenia Venture Capital invests mainly in life science companies based in Israel. Beyond financing, the firm supports portfolio companies with mentoring, business and strategic guidance, fundraising assistance, and exit planning. It holds a 50% stake in VLX, a technological incubator running under the Israel Innovation Authority's incubator program. Xenia actively looks for promising ideas with the potential to grow into multi-million dollar companies.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Tel Aviv, IL
Instruments
Equity
Founded
2003
Tracked investments
6

Team · 6 people

from the firm's website & curated & public directories

What they invest in

from 3 of 6 portfolio companies

Biotech ×3Medical Devices ×3Healthtech ×2

HQs:United States×1

Investments · 6 tracked

founders shown can be your intro path
Omnix Medicalomnixmedical.comin𝕏✓ verified

Omnix Medical is a biopharmaceutical company founded in 2015 that develops novel antibiotic agents to treat infections caused by drug-resistant bacteria.

BiotechHealthtechMedical Devices

Moshik Cohen-Kutnerin

Co-investorsTal VenturesEntrée CapitalOurCrowdVLX Ventures

Bio Protectbioprotect.comin𝕏

BioProtect develops a balloon spacer device for brachytherapy procedures, used to create spacing during cancer radiation treatment.

BiotechHealthtechMedical Devices

Itay Barnea(Chief Executive Officer)inDerek Webster(Chief Commercial Officer)inLee Adler(Chief Operating Officer)inShahar Shaked(Chief Financial Officer)inDafna Carmi-Yinon(Chief Product and Clinical Officer)in

Co-investorsAlmeda VenturesTriventuresMVM Life Science PartnersOlympus Innovation VenturesPeregrine Ventures

PolyPidpolypid.comin𝕏

PolyPid is a biopharmaceutical company developing long-acting, controlled-release medicines delivered at the site of care, with a lead product D-PLEX100 using its proprietary Kynatrix technology for preventing surgical site infections.

BiotechMedical DevicesPetach Tikva

Noam Emanuel(Executive Officer, Director)inAmir Weisberg(Executive Officer, Director)inDikla Czaczkes Akselbrad(Executive Officer)inOri Warshavsky(Executive Officer)inJacob Harel(Director)Yossi BenAmram(Director)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

KeepmedMedi-tatePlaycast

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Xenia Venture Capital made?
Xenia Venture Capital has 6 tracked investments.
What stage does Xenia Venture Capital invest at?
Xenia Venture Capital invests at the Seed, Series A stages.
What sectors does Xenia Venture Capital focus on?
Xenia Venture Capital focuses on Biotech, Data & Infrastructure, Enterprise Software, Hardware, Healthtech, Medical Devices, SaaS.
Where is Xenia Venture Capital located?
Xenia Venture Capital is headquartered in Tel Aviv, IL.
Who does Xenia Venture Capital co-invest with?
Xenia Venture Capital most often shares deals with Almeda Ventures, Olympus Innovation Ventures, Peregrine Ventures, among 4 tracked co-investors.

Similar investors

Featured in lists